• Corpus ID: 96446779

Stereotactic body radiotherapy for de novo spinal metastases : systematic review International Stereotactic Radiosurgery Society practice guidelines

@inproceedings{Husain2017StereotacticBR,
  title={Stereotactic body radiotherapy for de novo spinal metastases : systematic review International Stereotactic Radiosurgery Society practice guidelines},
  author={Zain A. Husain and Arjun Sahgal and Antonio A. F. De Salles and Melissa C Funaro and Janis G Glover and Motohiro Hayashi and Masahiro Hiraoka and Marc Levivier and Lijun Ma and Roberto Mart{\'i}nez‐{\'A}lvarez and J. Ian Paddick and Jean R{\'e}gis and Ben J. Slotman and Samuel Ryu},
  year={2017}
}
ABBREVIATIONS BED = biologically equivalent dose; CTV = clinical target volume; EBRT = external-beam radiation therapy; fx = fraction(s); GTV = gross tumor volume; ISRS = International Stereotactic Radiosurgery Society; MDACC = MD Anderson Cancer Center; RCC = renal cell carcinoma; SBRT = stereotactic body radiation therapy. SUBMITTED June 25, 2016. ACCEPTED January 6, 2017. INCLUDE WHEN CITING Published online June 9, 2017; DOI: 10.3171/2017.1.SPINE16684. Stereotactic body radiotherapy for de… 

Figures and Tables from this paper

Non-Surgical Ablative Treatment of Distant Extracranial Metastases for Renal Cell Carcinoma: A Systematic Review

No definite recommendations on the use of SBRT in metastatic RCC can be made because of the poor quality of the existing evidence, and Randomized trials are needed to assess impact on local control, symptom control, survival and toxicity.

Local control and patterns of failure for “Radioresistant” spinal metastases following stereotactic body radiotherapy compared to a “Radiosensitive” reference

Higher rates of LF were observed after spine SBRT in RR metastases and Optimization strategies include dose escalation and aggressive management of epidural disease.

Treatment planning for spinal radiosurgery

It is concluded that simple IMAT techniques can generate significantly better plan quality compared to previous established CKRS benchmarks.

Incidence and Time of Onset of Osseous Pseudoprogression in Patients With Metastatic Spine Disease From Renal Cell or Prostate Carcinoma After Treatment With Stereotactic Body Radiation Therapy

There was a higher incidence of PP in lytic compared to sclerotic primary tumor type and PP in spinal metastatic sites may have variable presentations depending on the primary cancer.

Photodynamic therapy outcome modelling for patients with spinal metastases: a simulation-based study

This work presents a framework for PDT modelling and planning, and simulates the feasibility of using a BPD-MA mediated PDT to treat bone metastases at two different wavelengths (690 nm and 565 nm), and provides a simulation platform that can be used to optimize PDT delivery in the metastatic spine.

Feasibility of postoperative spine stereotactic body radiation therapy in proximity of carbon and titanium hybrid implants using a robotic radiotherapy device

Dose calculation and delivery of postoperative spine SBRT is feasible in proximity of CFP-T implants using a CyberKnife system.

Population description and clinical response assessment for spinal metastases: part 2 of the SPIne response assessment in Neuro-Oncology (SPINO) group report

Recommendations for standardization of metrics used for spinal oncology patient population description and outcome assessment beyond local control endpoints on behalf of the SPIne response assessment in Neuro-Oncology (SPINO) group are provided.

Castration-resistant prostate cancer with bone metastases: toward the best therapeutic choice

The presently available and ongoing therapies for patients with CRPC andBone metastases are described, focusing on the role of bone metastases as a possible driver for selecting therapies in these patients.

References

SHOWING 1-10 OF 31 REFERENCES

Stereotactic body radiotherapy for spinal metastases: current status, with a focus on its application in the postoperative patient.

The focus of this review was to examine the evidence pertaining to spine SBRT in the treatment of spinal metastases and to provide a comprehensive analysis of published patterns of failure, with emphasis on the postoperative patient.

Local tumor control after retreatment of spinal metastasis using stereotactic body radiotherapy; comparison with initial treatment group

Retreatment of spinal metastases using SBRT provided effective local control without neurological complications, and overall survival, progression free survival, delivered radiation dose to tumor and spinal Cord, and spinal cord Pmax nBED were compared in two groups.

Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis

This multi-institutional cohort study reports high rates of efficacy with spine SBRT, and the optimal fractionation within high dose practice is unknown.

Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases.

Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.

Several factors associated with survival after spinal SRS for RCC metastases, including local progression, time between first metastasis and primary RCC diagnosis, KPS score, presence of neurological deficits, and progressive metastatic disease are identified.

Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture.

Spine SBRT yields high rates of local tumor control in patients with renal cell cancer spinal metastases and patients with oligometastatic disease may benefit most from such aggressive local therapy, given the prolonged survival observed.

Stereotactic radiosurgery compared with external radiation therapy as a primary treatment in spine metastasis from renal cell carcinoma: a multicenter, matched-pair study

This study showed that, when performed as a primary treatment in spine metastasis from RCC, SRS provides relatively better pain relief and better local control than that obtained from RT.

Single‐fraction radiosurgery for the treatment of spinal breast metastases

This study evaluated the clinical efficacy of the treatment of spinal breast carcinoma metastases with a single‐fraction radiosurgical technique.

Fiducial-free CyberKnife stereotactic body radiation therapy (SBRT) for single vertebral body metastases: acceptable local control and normal tissue tolerance with 5 fraction approach

Five-fraction fiducial-free CyberKnife SBRT is an acceptable treatment option for newly diagnosed VB metastases with promising local control rates and minimal toxicity despite the close proximity of such tumors to the spinal cord and esophagus.